import{_ as e,o as a,c as i,O as t}from"./chunks/framework.9482e208.js";const g=JSON.parse('{"title":"§ 54.1-3408.3 Certification for use of cannabis oil for treatment.","description":"","frontmatter":{},"headers":[],"relativePath":"vacode/54.1-3408.3.md","filePath":"vacode/54.1-3408.3.md"}'),r={name:"vacode/54.1-3408.3.md"},n=t('<h1 id="§-54-1-3408-3-certification-for-use-of-cannabis-oil-for-treatment" tabindex="-1">§ 54.1-3408.3 Certification for use of cannabis oil for treatment. <a class="header-anchor" href="#§-54-1-3408-3-certification-for-use-of-cannabis-oil-for-treatment" aria-label="Permalink to &quot;§ 54.1-3408.3 Certification for use of cannabis oil for treatment.&quot;">​</a></h1><p>A. As used in this section:</p><p>&quot;Botanical cannabis&quot; means cannabis that is composed wholly of usable cannabis from the same parts of the same chemovar of cannabis plant.</p><p>&quot;Cannabis oil&quot; means any formulation of processed Cannabis plant extract, which may include industrial hemp extracts, including isolates and distillates, acquired by a pharmaceutical processor pursuant to § <a href="/vacode/54.1-3442.6/">54.1-3442.6</a>, or a dilution of the resin of the Cannabis plant that contains no more than 10 milligrams of delta-9-tetrahydrocannabinol per dose. &quot;Cannabis oil&quot; does not include industrial hemp, as defined in § <a href="/vacode/3.2-4112/">3.2-4112</a>, that is grown, dealt, or processed in compliance with state or federal law, unless it has been grown and processed in the Commonwealth by a registered industrial hemp processor and acquired and formulated by a pharmaceutical processor.</p><p>&quot;Cannabis product&quot; means a product that is (i) produced by a pharmaceutical processor, registered with the Board, and compliant with testing requirements and (ii) composed of cannabis oil or botanical cannabis.</p><p>&quot;Designated caregiver facility&quot; means any hospice or hospice facility licensed pursuant to § <a href="/vacode/32.1-162.3/">32.1-162.3</a>, or home care organization as defined in § <a href="/vacode/32.1-162.7/">32.1-162.7</a> that provides pharmaceutical services or home health services, private provider licensed by the Department of Behavioral Health and Developmental Services pursuant to Article 2 (§ <a href="/vacode/37.2-403/">37.2-403</a> et seq.) of Chapter 4 of Title 37.2, assisted living facility licensed pursuant to § <a href="/vacode/63.2-1701/">63.2-1701</a>, or adult day care center licensed pursuant to § <a href="/vacode/63.2-1701/">63.2-1701</a>.</p><p>&quot;Practitioner&quot; means a practitioner of medicine or osteopathy licensed by the Board of Medicine, a physician assistant licensed by the Board of Medicine, or a nurse practitioner jointly licensed by the Board of Medicine and the Board of Nursing.</p><p>&quot;Registered agent&quot; means an individual designated by a patient who has been issued a written certification, or, if such patient is a minor or a vulnerable adult as defined in § <a href="/vacode/18.2-369/">18.2-369</a>, designated by such patient&#39;s parent or legal guardian, and registered with the Board pursuant to subsection G.</p><p>&quot;Usable cannabis&quot; means any cannabis plant material, including seeds, but not (i) resin that has been extracted from any part of the cannabis plant, its seeds, or its resin; (ii) the mature stalks, fiber produced from the stalks, or any other compound, manufacture, salt, or derivative, mixture, or preparation of the mature stalks; or (iii) oil or cake made from the seeds of the plant.</p><p>B. A practitioner in the course of his professional practice may issue a written certification for the use of cannabis products for treatment or to alleviate the symptoms of any diagnosed condition or disease determined by the practitioner to benefit from such use. The practitioner shall use his professional judgment to determine the manner and frequency of patient care and evaluation and may employ the use of telemedicine, provided that the use of telemedicine includes the delivery of patient care through real-time interactive audio-visual technology. If a practitioner determines it is consistent with the standard of care to dispense botanical cannabis to a minor, the written certification shall specifically authorize such dispensing. If not specifically included on the initial written certification, authorization for botanical cannabis may be communicated verbally or in writing to the pharmacist at the time of dispensing.</p><p>C. The written certification shall be on a form provided by the Board of Pharmacy. Such written certification shall contain the name, address, and telephone number of the practitioner; the name and address of the patient issued the written certification; the date on which the written certification was made; and the signature or authentic electronic signature of the practitioner. Such written certification issued pursuant to subsection B shall expire no later than one year after its issuance unless the practitioner provides in such written certification an earlier expiration. A written certification shall not be issued to a patient by more than one practitioner during any given time period.</p><p>D. No practitioner shall be prosecuted under § <a href="/vacode/18.2-248/">18.2-248</a> or <a href="/vacode/18.2-248.1/">18.2-248.1</a> for the issuance of a certification for the use of cannabis products for the treatment or to alleviate the symptoms of a patient&#39;s diagnosed condition or disease pursuant to a written certification issued pursuant to subsection B. Nothing in this section shall preclude the Board of Medicine from sanctioning a practitioner for failing to properly evaluate or treat a patient&#39;s medical condition or otherwise violating the applicable standard of care for evaluating or treating medical conditions.</p><p>E. A practitioner who issues a written certification to a patient pursuant to this section shall register with the Board and shall hold sufficient education and training to exercise appropriate professional judgment in the certification of patients. The Board shall not limit the number of patients to whom a practitioner may issue a written certification. The Board may report information to the applicable licensing board on unusual patterns of certifications issued by a practitioner.</p><p>F. No patient shall be required to physically present the written certification after the initial dispensing by any pharmaceutical processor or cannabis dispensing facility under each written certification, provided that the pharmaceutical processor or cannabis dispensing facility maintains an electronic copy of the written certification. Pharmaceutical processors and cannabis dispensing facilities shall electronically transmit, on a monthly basis, all new written certifications received by the pharmaceutical processor or cannabis dispensing facility to the Board.</p><p>G. A patient, or, if such patient is a minor or a vulnerable adult as defined in § <a href="/vacode/18.2-369/">18.2-369</a>, such patient&#39;s parent or legal guardian, may designate an individual to act as his registered agent for the purposes of receiving cannabis products pursuant to a valid written certification. Such designated individual shall register with the Board. The Board may set a limit on the number of patients for whom any individual is authorized to act as a registered agent.</p><p>H. Upon delivery of a cannabis product by a pharmaceutical processor or cannabis dispensing facility to a designated caregiver facility, any employee or contractor of a designated caregiver facility, who is licensed or registered by a health regulatory board and who is authorized to possess, distribute, or administer medications, may accept delivery of the cannabis product on behalf of a patient or resident for subsequent delivery to the patient or resident and may assist in the administration of the cannabis product to the patient or resident as necessary.</p><p>I. Information obtained under the registration process shall be confidential and shall not be subject to the disclosure provisions of the Virginia Freedom of Information Act (§ <a href="/vacode/2.2-3700/">2.2-3700</a> et seq.). However, reasonable access to registry information shall be provided to (i) the Chairmen of the House Committee for Courts of Justice and the Senate Committee on the Judiciary, (ii) state and federal agencies or local law enforcement for the purpose of investigating or prosecuting a specific individual for a specific violation of law, (iii) licensed practitioners or pharmacists, or their agents, for the purpose of providing patient care and drug therapy management and monitoring of drugs obtained by a patient, (iv) a pharmaceutical processor or cannabis dispensing facility involved in the treatment of a patient, or (v) a registered agent, but only with respect to information related to such patient.</p><p>2015, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?151+ful+CHAP0007" target="_blank" rel="noreferrer">7</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?151+ful+CHAP0008" target="_blank" rel="noreferrer">8</a>; 2017, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?171+ful+CHAP0613" target="_blank" rel="noreferrer">613</a>; 2018, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?181+ful+CHAP0246" target="_blank" rel="noreferrer">246</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?181+ful+CHAP0809" target="_blank" rel="noreferrer">809</a>; 2019, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+CHAP0653" target="_blank" rel="noreferrer">653</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+CHAP0654" target="_blank" rel="noreferrer">654</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+CHAP0681" target="_blank" rel="noreferrer">681</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?191+ful+CHAP0690" target="_blank" rel="noreferrer">690</a>; 2020, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0730" target="_blank" rel="noreferrer">730</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0831" target="_blank" rel="noreferrer">831</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0928" target="_blank" rel="noreferrer">928</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP1278" target="_blank" rel="noreferrer">1278</a>; 2021 Sp. Sess. I, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?212+ful+CHAP0205" target="_blank" rel="noreferrer">205</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?212+ful+CHAP0227" target="_blank" rel="noreferrer">227</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?212+ful+CHAP0228" target="_blank" rel="noreferrer">228</a>; 2022, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+CHAP0259" target="_blank" rel="noreferrer">259</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+CHAP0391" target="_blank" rel="noreferrer">391</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+CHAP0392" target="_blank" rel="noreferrer">392</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+CHAP0642" target="_blank" rel="noreferrer">642</a>.</p>',18),o=[n];function s(c,l,d,p,h,f){return a(),i("div",null,o)}const m=e(r,[["render",s]]);export{g as __pageData,m as default};
